Variant · Deletion Cna
CREBBP Deletion
CI-VAR-00000635Explore in graph →CIViC 856
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 26603525
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Lung Non-Small Cell Carcinoma1 | ||||||||
| CREBBP Deletion | C646 | Predictive | D | Supports Sensitivity Response | 3 | submitted | EID1965Ablation of the CBP paralog p300/EP300 has been identified as syntheticaly lethal in in CBP-knockout and CBP-deficient cancer cells and induced a G1-S cell-cycle arrest, followed by apoptosis. Genome-… (full text at CIViC) PMID 26603525 · Ogiwara et al., 2016 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available